Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Research and trials

Showing 12 out of 1686 results
A photo of Michelle Mitchell, Wes Streeting and Deborah's family members at the Crick

Today, Michelle Mitchell, our chief executive, met Wes Streeting at the Bowelbabe Lab in the Crick Institute to discuss why cancer must remain a government priority Today, Michelle Mitchell, our chief executive, met Wes Streeting at the Bowelbabe Lab in the Crick Institute to discuss why cancer must remain a government priority

by Michelle Mitchell | Opinion | 23 April 2025

23 April 2025

A union jack and EU flag tied together

As we launch our new report, “Nothing should stand in the way”, we reflect on how the UK and EU could be more ambitious, grasping opportunities for closer scientific cooperation to promote health and wealth across the continent and beyond As we launch our new report, “Nothing should stand in the way”, we reflect on how the UK and EU could be more ambitious, grasping opportunities for closer scientific cooperation to promote health and wealth across the continent and beyond

by Laura Williams | Analysis | 22 April 2025

22 April 2025

Microscopy image of a prostate tumour

We set out why we believe there are currently no easy solutions to prostate cancer early diagnosis, and what we’re doing at Cancer Research UK to change that. We set out why we believe there are currently no easy solutions to prostate cancer early diagnosis, and what we’re doing at Cancer Research UK to change that.

by Cancer Research UK | In depth | 14 April 2025

14 April 2025

This entry is part 24 of 26 in the series That Cancer Conversation
Microscope image of human colon cancer cells
  • Science & Technology
  • Health & Medicine

Bowel cancer awareness month: Common questions answered

To help raise awareness around bowel cancer, and the research we are doing, we’re answering some the most common questions on bowel cancer. To help raise awareness around bowel cancer, and the research we are doing, we’re answering some the most common questions on bowel cancer.

by Amy Warnock | In depth | 1 April 2025

1 April 2025

Researchers discussing work in lab

Along with our partners, we've committed £5.5m in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer. Along with our partners, we've committed £5.5m in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer.

by Fiona Scott | News | 31 March 2025

31 March 2025

A corridor of computer servers

To get the most out of data-driven programmes we need to see some changes in the UK’s health data infrastructure. Here we explore what those changes need to be, and how programmes like CD3 can align with government’s priorities.  To get the most out of data-driven programmes we need to see some changes in the UK’s health data infrastructure. Here we explore what those changes need to be, and how programmes like CD3 can align with government’s priorities. 

by Ben Jones | Analysis | 19 March 2025

19 March 2025

This entry is part 23 of 26 in the series That Cancer Conversation
The DETERMINE trial team celebrating at the Bionow awards

Since launching in December 2021, the DETERMINE trial has hit many milestones on the way to providing much needed treatment options for people with rare cancers, including treating its 100th patient. On Rare Disease Day, we look back at some of those key achievements. Since launching in December 2021, the DETERMINE trial has hit many milestones on the way to providing much needed treatment options for people with rare cancers, including treating its 100th patient. On Rare Disease Day, we look back at some of those key achievements.

by Tim Bodicoat | In depth | 28 February 2025

28 February 2025